Last reviewed · How we verify

NCT07312838

Evaluation of Glycemic Impact on Fetal Liver Length and Volume by Ultrasound in Pregnancy

Not yet recruiting Last updated 31 December 2025
What this trial tests

trial in Gestatiaonl Diabetes Mellitus in 115 participants. Not yet recruiting.

Timeline
1 January 2026
Primary endpoint
28 March 2028
28 March 2028

Quick facts

Lead sponsorAssiut University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment115
Start date1 January 2026
Primary completion28 March 2028
Estimated completion28 March 2028

Conditions studied

Sponsor

Assiut University

Who can join

Adults 18 to 52, female only, with Gestatiaonl Diabetes Mellitus or FETAL LİVER VOLUME. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of this study is to evaluate whether fetal liver length and volume, as assessed by ultrasound, can serve as reliable markers of the metabolic impact of Gestational Diabetes Mellitus (GDM) on the fetus.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gestatiaonl Diabetes Mellitus

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07312838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing